Author:
Ferkul Sean,Agabani Zena,Minami Osamu,Bormann Jill,Le Foll Bernard,Lobo Leah,Hassan Ahmed N.
Abstract
Abstract
Background
There is a need for expanded options for therapeutic interventions for patients with posttraumatic stress disorder (PTSD) and substance use disorder (SUD). The study aimed to examine evidence for the feasibility, safety, and acceptability of a virtual Mantram Repetition Program for adults with PTSD and SUD.
Methods
This project utilized mixed-method design (explanatory sequential design) to collect quantitative and qualitative data to evaluate the program in terms of its feasibility and acceptability. The program took place over Webex, an encrypted virtual platform. The group ran over 8 weeks, was 90 min in length, and facilitated by two individuals per cohort. Each group had 4–5 participants given each group cycle.
The study used the Mantram Repetition Program which is a brief mindfulness based non-tramua focused group intervention.
Results
Out of 43 participants enrolled, 5 people (11.6%) did not commence the program and 8 (18.6%) participants dropped out after commencing the program, resulting in 35 completers (81.4% retention rate). Treatment completion and retention were above 70%. Qualitative data explained several aspects of the program’s acceptability including delivery methods, informative material provided and gaining a practical mindful tool to manage symptoms.
Conclusions
This study showed quantitative and qualitative evidence of the Mantram Repetition Program’s feasibility, acceptability and safety to be used with individuals with PTSD-SUD. Although further evaluation of virtual Mantram Program to control group in longitudinal trials is needed to identify how it compares with other interventions in the field.
Clinical trial registration number
NCT05058963, (28/09/2021).
Funder
The Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centers of Ontario
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th Edition (DSM-5). Diagnostic Stat Man Ment Disord. 2013;280:1414–25.
2. Pietrzak RH, Goldstein RB, Southwick SM, Grant BF. Prevalence and axis i comorbidity of full and partial posttraumatic stress disorder in the united states: results from wave 2 of the national epidemiologic survey on alcohol and related conditions. J Anxiety Disord. 2011;25(3):456–65.
3. Banerjee S, Spry C. Concurrent treatment for substance use disorder and trauma-related comorbidities: a review of clinical effectiveness and guidelines. Crit Apprais. 2017;16:1–42. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525683/. Cited 2022 Dec 15.
4. Leconte C, Mongeau R, Noble F. Traumatic stress-induced vulnerability to addiction: critical role of the dynorphin/kappa opioid receptor system. Front Pharmacol. 2022;13:856672. Available from: https://pubmed.ncbi.nlm.nih.gov/35571111/. Cited 2022 Dec 15.
5. Vujanovic AA, Farris SG, Bartlett BA, Lyons RC, Haller M, Colvonen PJ, et al. Anxiety sensitivity in the association between posttraumatic stress and substance use disorders: a systematic review. Clin Psychol Rev. 2018;62:37–55. Available from: https://pubmed.ncbi.nlm.nih.gov/29778929/. Cited 2022 Dec 15.